JAK2 activation in myeloproliferative neoplasms: a potential role for heterodimeric receptors

Gary W Reuther1

  • 1H. Lee Moffitt Cancer Center, Tampa, Florida 33612, USA. gary.reuther@moffitt.org

Insights

The Janus kinase 2 (JAK2)-V617F mutation is crucial in myeloproliferative neoplasms. This study reveals that heterodimeric cytokine receptors, not just homodimeric ones, can activate mutant JAK2, offering new therapeutic insights.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • The Janus kinase 2 (JAK2) plays a significant role in cellular signaling pathways.
  • A specific point mutation, JAK2-V617F, identified in 2005, is implicated in various myeloproliferative neoplasms (MPNs).
  • This mutation presents a potential therapeutic target for MPNs and their progression to cancer.

Purpose of the Study:

  • To elucidate the precise mechanism of JAK2-V617F-mediated activation.
  • To understand the contribution of JAK2 to the pathogenesis of MPNs.
  • To explore the role of cytokine receptors in JAK2 activation.

Main Methods:

  • Investigated the role of homodimeric and heterodimeric cytokine receptors in JAK2-V617F activation.
  • Analyzed the mechanism of JAK2 trans-activation via phosphorylation.
  • Examined potential contributions of receptor components in JAK2-negative MPNs.

Main Results:

  • Mutationally activated JAK2-V617F requires cytokine receptors for trans-activation.
  • Both homodimeric and single components of heterodimeric cytokine receptors can serve as scaffolds for JAK2-V617F activation.
  • Aberrant expression or mutation of heterodimeric receptor components may contribute to JAK2-negative MPNs.

Conclusions:

  • The activation mechanism of JAK2-V617F involves cytokine receptor scaffolds.
  • Heterodimeric cytokine receptors represent a novel pathway for JAK2 activation in MPNs.
  • Further research into heterodimeric receptor components could reveal new therapeutic strategies for MPNs.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...